GlassScriptPhysician profile
Robert Richard Wells
NPI 1578511408
$751.06
in general payments reported to CMS, 2019-2025
14 companies · $82.32 in 2025
The $82.32 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $36.47 · 2021: $76.27 · 2022: $138 · 2023: $240 · 2024: $75.85 · 2025: $82.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Education: $23.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.59 |
| Education | $23.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $176.98 | 2023 | Xeomin |
| Organon LLC | $126.79 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $83.81 | 2019-2024 | Injectafer |
| Ethicon US, LLC | $70.19 | 2019-2025 | Vistaseal, Ethicon |
| Pfizer INC. | $64.43 | 2022-2023 | |
| Abbvie INC. | $38.47 | 2019 | |
| Merck Sharp & Dohme LLC | $35.03 | 2020-2021 | |
| Intuitive Surgical, INC. | $33.33 | 2022 | |
| Hologic Sales and Service, LLC | $30.09 | 2020-2021 | |
| Exact Sciences Corporation | $25.34 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $22.60 | 2022 | |
| Axsome Therapeutics, INC. | $16.94 | 2023 | Auvelity |
| Roche Diagnostics Corporation | $13.98 | 2019 | |
| Acell, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.